The Law Office Of Abe Shainberg Launches An Investigation Into The Possible Breaches Of Fiduciary Duty By The Board Of Martek Biosciences Corporation In Connection With Sale Of Company To Royal DSM N.V. – MATK
The Law Office of Abe Shainberg is investigating the Board of Directors of Martek Biosciences Corporation (NasdaqGS: MATK) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Royal DSM N.V. (NYSE: DSM). Under the terms of the transaction, Martek stockholders will receive $31.50 in cash per share for a total transaction value of approximately $1.09 billion.
The investigation concerns whether the Martek Board of Directors breached their fiduciary duties to Martek stockholders by failing to adequately shop the Company before entering into this transaction and whether Royal DSM is underpaying for Martek shares.
If you own common stock in Martek and wish to obtain additional information, please contact Abe Shainberg, Esq. either via email at email@example.com or by telephone at (212) 425-7286, or visit http://www.ashainberglaw.com/martek-biosciences.html.
Mr. Shainberg has expertise in prosecuting investor securities litigation, is a certified and registered arbitrator and mediator involving financial matters, and represents investors in various matters nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV